Identification of relevant biomarkers for type 2 diabetes

Affiliations

¹ MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. Electronic address: ali.abbasi@mrc-epid.cam.ac.uk.
² Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
³ Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Comment

Ali Abbasi et al. Lancet Diabetes Endocrinol. 2014 Feb.

. 2014 Feb;2(2):106-7.

doi: 10.1016/S2213-8587(14)70005-1. Epub 2014 Feb 3.

¹ MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. Electronic address: ali.abbasi@mrc-epid.cam.ac.uk.
² Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
³ Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

No abstract available

Comment on

Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome.
Roberts LD, Koulman A, Griffin JL. Roberts LD, et al. Lancet Diabetes Endocrinol. 2014 Jan;2(1):65-75. doi: 10.1016/S2213-8587(13)70143-8. Epub 2013 Dec 3. Lancet Diabetes Endocrinol. 2014. PMID: 24622670 Review.